Organigram Global Inc. · TSX:OGI

Organigram Global — Q1 2022 Earnings Presentation

36 slides from Organigram Global's earnings presentation, Jan 11, 2022

  1. Slide 1: Organigram Investor Presentation Q1 Fiscal 2022

    ORGANIGRAM INVESTOR PRESENTATION Q1 FISCAL 2022 NASDAQ (OGI) TSX (OGI)

  2. Slide 2: Cautionary Statement

    CAUTIONARY STATEMENT This document is current as of January 11, 2022, except where otherwise stated. The information contained Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this presentation is provided by Organigram Holdings Inc.

  3. Slide 3: Strategy

    INNOVATION CONSUMER FOCUS EFFICIENCY EXPANSION STRATEGY: Leverage our brands, product portfolio and culture of innovation to: 2 Increase Drive Deliver long-term Reach market share profitability shareholder value new markets

  4. Slide 4: Key Strengths

    KEY STRENGTHS LEADING LICENSED THREE LEVEL INDOOR DEDICATED EDIBLES AND PRODUCER CULTIVATION DERIVATIVES FACILITIES Leading licensed producer Large indoor facility in Moncton: vape filling, CO2 extraction (LP) of quality products for Moncton, NB with unique Winnipeg: Specialized edibles, Recreationa

  5. Slide 5: Building a Market Leader

    BUILDING A MARKET LEADER CANADIAN REC. MARKET SHARE BY $ SALES (HIFYRE) • Since Q2 Fiscal 2021: moved from 6th to 4th market share position 7.5% • As of December 2021, Organigram has secured the 7.0% top 3 market positions nationally in 3 out of the 6 product categories in which we participate, with

  6. Slide 6: Continuing a Trend of Growth

    CONTINUING A TREND OF GROWTH REVENUE $44.3 $ millions Compound quarterly growth last three quarters: $36.2 Net revenue: 27.7% Gross revenue: 31.9% $30.4 $29.1 $24.9 $20.3 $19.3 $14.6 Q2 F21 Q3 F21 Q4 F21 Q1 F22 Net Revenue Gross Revenue 5

  7. Slide 7: Q1-2022 Highlights

    Q1-2022 HIGHLIGHTS • Record high quarterly net revenue • Maintained recreational market share position as #4 Canadian LP with 7.5% market share1 • SHRED popularity continues with 2 SKUS reaching #1 and #2 positions as the best-selling flower products in Canada in both November and December 1 • SHRED

  8. Slide 8: Strong Balance Sheet and Liquidity

    STRONG BALANCE SHEET AND LIQUIDITY • Capital position is healthy and there is sufficient liquidity available for the near to medium term • On November 30, 2021, the Company had cash and short-term investments (excluding restricted funds) of $168 million • Negligible debt (less than $0.3 million) 7

  9. Slide 9: Fiscal 2022 Outlook

    FISCAL 2022 OUTLOOK1 • Expecting a solid Q2 F22 net revenue which will be significantly higher than Q2 F21 due to: • Addition of Laurentian and its premium products and high margin brands into the Organigram portfolio • Stronger forecasted market growth as the retail network expands • Strong market

  10. Slide 10: Q1 Fiscal 2022 Select Key Financial Metrics

    Q1 FISCAL 2022 SELECT KEY FINANCIAL METRICS Select Key Financial Metrics (in $000s unless otherwise indicated) Q1-2022 Q1-2021 % Change Gross revenue 44,345 25,280 75 % Excise taxes (13,967) (5,949) 135 % Net revenue 30,378 19,331 57 % Cost of sales 27,924 23,173 21 % Gross margin before fair value

  11. Slide 11: Solid Revenue Growth in Q1 F22

    SOLID REVENUE GROWTH IN Q1 F22 $ millions TOTAL Revenue RECREATIONAL Revenue1 $44.3 $38.8 75% Increase $30.4 73% Increase $25.3 $25.0 57% $22.5 $19.3 Increase $16.8 49% Increase Q1 F21 Q1 F22 Q1 F21 Q1 F22 Net Revenue Gross Revenue Net Revenue Gross Revenue 10 1) Recreational Revenue is a non-IFRS M

  12. Slide 12: Potential Upside for Gross Margins

    POTENTIAL UPSIDE FOR GROSS MARGINS1 • Acquisition of Laurentian expected to increase gross margin and EBITDA mix starting in Q2 20222; • Improved economies of scale and efficiencies as cultivation and production volumes continue to increase; • Continued investment in automation which will drive cost

  13. Slide 13: Well-Rounded Brand Portfolio

    WELL-ROUNDED BRAND PORTFOLIO NEW NEW NEW Pricing Value Value Value Mainstream Mainstream Premium Craft Segment Pre-Milled Flower, Whole Flower, Whole Flower, Available / Pre-Roll Joint Pre-Roll Joints, Pre-Roll Joints, Afghan Hash Craft Flower Planned Whole Flower CBD Gummies Premium Flower Multipac

  14. Slide 14: Laurentian Acquisition Bolsters Product Portfolio

    LAURENTIAN ACQUISITION BOLSTERS PRODUCT PORTFOLIO • Highly accretive on both a revenue and EBITDA basis with an average annual gross and net revenue of $22 million and + $17 million and an annual EBITDA run rate of $6 million • Accelerates and strengthens Organigram’s presence in the Quebec market w

  15. Slide 15: Laurentian At-a-Glance

    LAURENTIAN AT-A-GLANCE COMPANY PORTFOLIO OPERATION AND FACILITIES • Established in 2020 • Premium Afghan hash SKUs: • Health Canada licensed • Located in Lac-Superieur, QC, 2.0g & 3.5g sizes • Greenhouse capacity expanding from near Mont-Tremblant • Craft flower: 600kg to 3,000kg of craft flower by

  16. Slide 16: State-of-Art, Three Tier Cultivation Centre

    STATE-OF-ART, THREE TIER CULTIVATION CENTRE • Moncton, New Brunswick • Strain-specific grow rooms • Micro-climates provide the ability to control all critical factors affecting the growing environment • Phase 4C (under construction) and design improvements to Moncton grow rooms expected to result in

  17. Slide 17: Premium Quality Cannabis and Hash Production

    PREMIUM QUALITY CANNABIS AND HASH PRODUCTION • Lac-Supérieur, Quebec (near Mont-Tremblant) • Producer of hang dried, trimmed by hand, artisanal craft cannabis, and “old school” Afghan-style hash • Greenhouse capacity expanding from 600kg to 3,000kg1 of craft flower by the end of calendar 2022 • Hash

  18. Slide 18: Dedicated Edibles and Derivatives Facilities

    DEDICATED EDIBLES AND DERIVATIVES FACILITIES • Winnipeg-based wholly-owned subsidiary: The Edibles and Infusions Corporation (EIC) • Designed to meet EU-GMP certification standards1 • Purpose built, highly automated, 51,000 square foot facility with state-of-the-art equipment • Designed to produce n

  19. Slide 19: Investment in Disruptive Technology-Biosynthesis

    INVESTMENT IN DISRUPTIVE TECHNOLOGY-BIOSYNTHESIS • Subsequent to Q1 2022, Organigram increased its investment in Hyasynth, a pioneer in cannabinoid science, in which Organigram has the option to purchase Hyasynth’s BIOSYNTHESIS How it works? proprietary biosynthesis-generated cannabinoids A propriet

  20. Slide 20: Product Development Collaboration & Strategic Investment

    PRODUCT DEVELOPMENT COLLABORATION & STRATEGIC INVESTMENT Transaction Highlights Strategic Rationale • ~C$221M strategic investment from subsidiary of BAT for 19.9% equity interest1 in Organigram • Product Development Collaboration with formation of • Accelerates and strengthens Organigram’s R&D a Ce

  21. Slide 21: Alignment of Capabilities & Resources

    ALIGNMENT OF CAPABILITIES & RESOURCES LEADING CONSUMER GOODS BUSINESS LEADING LICENSED PRODUCER OF HIGH- QUALITY CANNABIS PRODUCTS SOPHISTICATED MANAGEMENT STATE-OF-THE-ART FACILITIES INNOVATIVE PRODUCT PLATFORMS EXPERIENCED MANAGEMENT TEAM DEEP PLANT EXPERTISE WITH DEEP CANNABIS EXPERTISE DEEP CONS

  22. Slide 22: Key International Supply Agreement

    KEY INTERNATIONAL SUPPLY AGREEMENT • On June 9, 2020, entered into a multi-year agreement for supply of dried flower to one of Israel’s largest and most established medical cannabis producers, Canndoc Ltd., a pioneer in pharmaceutical-grade cannabis for more than 12 years • Canndoc’s GMP-approved me

  23. Slide 23: Solid Projected Growth in Rec Market

    SOLID PROJECTED GROWTH IN REC MARKET CANADIAN ADULT-USE RECREATIONAL MARKET – CALENDAR YEARS (EXCLUDES MEDICAL) $ billions $8.2 $7.9 $7.5 Ontario $6.9 556 $5.9 2022 2023 2024 2025 2026 Source: BDSA, September 2021 22

  24. Slide 24: 191% Growth in Retail Stores

    191% GROWTH IN RETAIL STORES CANNABIS RETAIL STORES NUMBER OF ONTARIO RETAIL STORE IN 10 PROVINCES 2,803 AUTHORIZATIONS PER MONTH Today* Increase of 191% Sept- Dec- 2020 2020 963 ONTARIO Increase of 40 100 20 80 102 ONTARIO 1152% 1,277 Jul-2020 Nov-2021 Quadrupled ONTARIO GREW 1152% | Canada’s 10 pr

  25. Slide 25: Appendix

    APPENDIX

  26. Slide 26: BAT Transaction Summary

    BAT TRANSACTION SUMMARY • Subsidiary of BAT subscribed for 58.3M common shares of Organigram, which represents a 19.9% equity interest1 on a post-transaction basis, at a price of C$3.792 per share Investment • Total proceeds to Organigram of ~C$221 million (the “Investment Proceeds”) • The price per

  27. Slide 27: Edison brand products

    At Edison, we believe in using scientific rigour to grow high-quality flower and to cultivate a deeper appreciation for the cannabis plant. We hunt for the most promising genetics and use our unique science-based growing methods to maximize the best attributes of every plant and product. Feather 510

  28. Slide 28: Big Bag 'O' Buds

    Not all flower is worthy of an ounce, unless you’re Big Bag ‘O’ Buds. We cultivate the best to give you big terps and big buds, all in a big bag. Ice Cream Cake 28g Lemon Margy 28g Ultra Sour 28g 27

  29. Slide 29: SHRED

    SHRED is here to make your cannabis experience easier. From roll to bowl, SHRED is pre-milled, high-quality whole- flower that’s ready-to-use. You can trust that every pouch is top-shelf, never shake. And you won’t find stems or sticks, either just pre-milled nugs with at least 18% THC. Shred 7g | 1

  30. Slide 30: SHRED'ems gummies

    Introducing the squishy sequel to SHRED – our new infused gummies called SHRED’ems. These gummies are squishy explosions of flavour you can pop right into your mouth. All you have to do is drop in and send it. Shred’ems Gummies 2 x 5 mg THC | 4 x 2.5 mg THC 29

  31. Slide 31: Monjour CBD gummies

    Be it physical, mental or spiritual balance you are searching for, Monjour’s range of vegan and sugar-free CBD gummies provide an easy and delicious way to incorporate a moment of wellness in your everyday. Monjour 30 x 20 mg CBD Monjour Bare 30 x 20 mg CBD 30

  32. Slide 32: Trailblazer brand

    The Trailblazer brand stays true to its name, offering quality cannabis products in ready-to-use, convenient and innovative formats. Be it delicious chocolates, flavourful flower, or portable pre-rolls, we have the cannabis for the moments of brightness to keep you blazing on. Torch 510 Distillate V

  33. Slide 33: Laurentian and Tremblant products

    Laurentian produces artisanal craft cannabis. Grown in a greenhouse under the sun, we offer a selection of flowers that are hand crafted and cured to perfection. Tremblant’s old-school hashish is reminiscent of the 80’s. Black on the outside and brown on the inside, this hashish has spicy and rich n

  34. Slide 34: Q1 Fiscal 2022 Select Balance Sheet Metrics

    Q1 FISCAL 2022 SELECT BALANCE SHEET METRICS NOVEMBER 30, AUGUST 31, Select Balance Sheet Metrics (in $000s) % Change 2021 2021 Cash & short-term investments 168,035 183,555 (8) % Biological assets & inventories 46,420 48,818 (5) % Other current assets 32,800 28,242 16 % Accounts payable & accrued li

  35. Slide 35: Capital Structure

    Q1 FISCAL 2021 CAPITAL STRUCTURE NOVEMBER 30, AUGUST 31, in $000s 2021 2021 Current and long-term debt 291 310 Shareholders’ equity 482,685 479,805 Total debt and shareholders’ equity 482,976 480,115 in 000s Outstanding common shares 299,849 232,088 Options 8,106 7,797 Warrants 16,944 16,944 Top-up

  36. Slide 36: An Emerging Cannabis Industry Leader

    An Emerging Cannabis Industry Leader NASDAQ (OGI) TSX (OGI)

Organigram Holdings — Q1 2022 Earnings Presentation on 6ix